‘Global Pharma Clinical Trial Services Market Worth $61.92bn In 2021’ Says Visiongain Report

15 August 2018
Pharma

Visiongain’s new report Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases indicates that the pharma clinical trial sales market will see $61.92bn in spending in 2021.

The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.8% from 2016-2027. The pharma clinical trial services market is estimated at $39.56bn in 2016 dominated by the late-phase services, which held 56% of share.
The lead analyst of the report said: “The pharma clinical trial services market is driven by several factors, which include the rise in research and development activities by biopharmaceutical organizations, increasing importance of contract research organizations in the emerging markets, and growth in biopharmaceutical research and development expenditures.
However, challenges such as patient recruitment and retention as well as regulatory challenges are some of the factors hampering the growth of this market.”
The 188-page report contains 145 charts that add visual analysis in order to explain the developing trends within the pharma clinical trial services market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments by type of services (early phase, late phase and other services), end-users (pharma, biotech companies and other end-users) and therapeutic area (Cancer, Cardiovascular, CNS, Infectious Diseases, Metabolic Diseases and other Diseases).
The 188-page report offers market forecasts for the US, Rest of North America, Germany, UK, France, Italy, Spain, Russia, Central and Eastern Europe, Rest of Europe, China, Japan, India, South Korea, Rest of APAC, Latin America, Brazil, Middle East and Africa.

Moreover, our work discusses the leading companies in the pharma clinical trial services market.

The report Pharma Clinical Trial Services Market and Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases report will be of value to anyone who wants to better understand the pharma clinical trial services market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the pharma clinical trial services market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever